Clinical and molecular characteristics of <i>RNF43</i> mutations as promising prognostic biomarkers in colorectal cancer.

Authors:
Huang ZY; Wen L; Ye LF; Lu YT; Pat Fong W and 8 more

Journal:
Ther Adv Med Oncol

Publication Year: 2024

DOI:
10.1177/17588359231220600

PMCID:
PMC10777808

PMID:
38205077

Journal Information

Full Title: Ther Adv Med Oncol

Abbreviation: Ther Adv Med Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors declare that there is no conflict of interest."

Evidence found in paper:

"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported, in part, by the Guangdong Basic and Applied Basic Research Foundation (Grand number: 2023B1515020015); National Natural Science Foundation of China (Grant numbers: 82073302, 81930065, 82173128); the Fundamental Research Funds for the Central Universities, Sun Yat-sen University (Grand number: 22qntd4001); the CAMS Innovation Fund for Medical Sciences (CIFMS) (Grant number: 2019-I2M-5-036); Beijing Health Alliance Charitable Foundation (Grand number: BJHA-CRP-058). The funders played no role in designing the study, collecting, analyzing, or interpreting data, nor did they contribute to the writing of the manuscript."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025